Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Editor's note: This article has been updated with a comment from Hims & Hers CEO and the company. Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer ...

Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hims & Hers Health (HIMS) stock saw it’s shares drop more than 30% during trading on Monday. The sharp decline was one of the steepest one-day drops in the stock’s history. HIMS shares fell after Novo ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space. This is bringing a new class of tech-driven innovators to the forefront.

Hims & Hers teams up with Novo Nordisk to bundle Wegovy into a $599/month telehealth care plan. Investors see Amazon-like potential as Hims scales affordable healthcare through platform-based ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading 1.7% lower at $40.13 Monday morning. The company earlier appointed Nader Kabbani as its new Chief Operations Officer, signaling a strategic push ...

Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and GoodRx Holdings, ...